Combined Carfilzomib and Hydroxychloroquine in Patients With Relapsed/Refractory Multiple Myeloma

NCT04163107 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Hydroxychloroquine
DRUG: Carfilzomib Injection
DRUG: Dexamethasone

Sponsor

Norwegian University of Science and Technology

Collaborators

[object Object]
[object Object]